For research use only. Not for therapeutic Use.
Ethyl acetoacetate-d3 (CAS: 1565868-21-4), a premium pharmaceutical research compound designed for advanced studies in organic synthesis and metabolic research. As a deuterated analog of Ethyl acetoacetate, it offers enhanced stability and improved isotopic labeling properties. Ethyl acetoacetate-d3 is ideal for use in pharmacological, biochemical, and synthetic chemistry research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel compounds and metabolic pathways. Trusted by leading laboratories, Ethyl acetoacetate-d3 is your go-to solution for cutting-edge research. Unlock new possibilities in organic synthesis and metabolic studies with Ethyl acetoacetate-d3, where innovation meets reliability.
| Catalog Number | S000226 |
| CAS Number | 1565868-21-4 |
| Molecular Formula | C6H7D3O3 |
| Purity | ≥95% |
| Target | Bacterial |
| IUPAC Name | ethyl 4,4,4-trideuterio-3-oxobutanoate |
| InChI | InChI=1S/C6H10O3/c1-3-9-6(8)4-5(2)7/h3-4H2,1-2H3/i2D3 |
| InChIKey | XYIBRDXRRQCHLP-BMSJAHLVSA-N |
| SMILES | [2H]C([2H])([2H])C(=O)CC(=O)OCC |
| Reference | [1]. Rao M.Uppu, et al. Enantioselective catalytic asymmetric hydrogenation of ethyl acetoacetate in room temperature ionic liquids. Biochemical and Biophysical Research Communications. 1996 Dec; 229(3):764-769. [2]. Leo F. Salter, et al. A dual‐frequency Belousov Zhabotinskii oscillating reaction with ethyl acetoacetate as organic substrate. substrate. International Journal of Chemical Kinetics. 1982. 14(8), 815–821. [3]. Iqbal S, et al. 2-Oxo-1,2,3,4-tetrahydropyrimidines Ethyl Esters as Potent β- Glucuronidase Inhibitors: One-pot Synthesis, In vitro and In silico Studies. Med Chem. 2018;14(8):818-830. [4]. Horne SM, et al. Acetoacetate and ethyl acetoacetate as novel inhibitors of bacterial biofilm. Lett Appl Microbiol. 2018 Apr;66(4):329-339. [5]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223. |
